Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs28630738 | chr2:242558777 | C/T | 4.1E-11 | 178 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs28631991 | chr18:44150258 | G/A | 1.01E-7 | 176 | 25.17 | 27.4 | 19.87 | KM Plot |
PCPG | rs28643511 | chr16:89590060 | G/A | 0.000192 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |
PCPG | rs28648517 | chr17:74704972 | T/C | 0.000173 | 175 | 25.97 | 14.63 | 13.5 | KM Plot |
PCPG | rs28655575 | chr10:29854065 | C/T | 5.6E-11 | 176 | 25.67 | 17.52 | 10.3 | KM Plot |
PCPG | rs28661943 | chr16:89960618 | C/T | 0.000226 | 170 | 25.87 | 20.13 | 36.37 | KM Plot |
PCPG | rs28668543 | chr11:46273454 | G/A | 4.62E-5 | 175 | 25.53 | 25.17 | 25.4 | KM Plot |
PCPG | rs28668669 | chr4:4531182 | C/G | 0.000293 | 175 | 25.47 | 25.87 | 19.22 | KM Plot |
PCPG | rs28684616 | chr17:53763943 | T/A | 0.000133 | 173 | 25.87 | 17.93 | 17.27 | KM Plot |
PCPG | rs2869492 | chr16:12071341 | T/C | 0.000272 | 174 | 25.33 | 26.05 | 24.35 | KM Plot |
PCPG | rs28700192 | chr8:126190872 | G/A | 2.95E-5 | 178 | 25.35 | 28.3 | 4.17 | KM Plot |
PCPG | rs28710979 | chr16:1738770 | C/T | 0 | 173 | 25.53 | 19.3 | 2.93 | KM Plot |
PCPG | rs2873438 | chr6:123123651 | T/C | 1.46E-8 | 173 | 7.03 | 26.53 | 24.85 | KM Plot |
PCPG | rs28753220 | chr17:80515202 | C/T | 4.21E-5 | 178 | 25.97 | 19.72 | 7.2 | KM Plot |
PCPG | rs28846155 | chr17:80515071 | G/A | 4.21E-5 | 178 | 25.97 | 19.72 | 7.2 | KM Plot |